MiroBio

MiroBio's mission is to develop novel, first-class therapies that bring significant benefits to patients with various autoimmune diseases. MiroBio's drugs will activate natural mechanisms to regain control over the overactive immune responses that trigger these diseases. MiroBio’s platform is based on the groundbreaking research of its scientific founders at Oxford University, which describes how immune cells communicate and become activated. These insights have enabled MiroBio to create antibodies that can harness natural signaling mechanisms to restore balance and control to the immune system.